Depression dosing study pulled before it began
NCT ID NCT05210153
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study planned to check if measuring sertraline levels in the blood and looking at a specific gene (CYP2C19) could help doctors give the right dose to people with major depression. It aimed to see if many patients get too much or too little medicine with standard dosing. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Centre of Serbia
Belgrade, 11000, Serbia
-
Institute of Mental Health
Belgrade, 11000, Serbia
-
Military Medical Academy
Belgrade, 11000, Serbia
Conditions
Explore the condition pages connected to this study.